ArticleInternational journal of urology : official journal of the Japanese Urological Association2025

Post-marketing surveillance data for avelumab + axitinib treatment in patients with advanced renal cell carcinoma in Japan: Subgroup analyses by pathological classification.

Norio Nonomura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.